Atika Capital Management LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1599731
NEW YORK, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,907,199
+$539,960 QoQ
Shares Held
440,000
-7.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#124
of 671 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Jun 30, 2026CallValue
$33,879
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Atika Capital Management LLC holds $19,289,967 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (77.3% of the industry book) .
All Filings in TEVA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,879 | 1,000 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $14,907,199 | 440,000 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,367,239 | 477,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $22,377,569 | 717,000 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $93,628 | 3,000 | Call | Defined | 2026-02-13 | |
| 2025-09-30 | $4,524,798 | 224,000 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $6,715,151 | 436,900 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||